logo
Eltropy Advances Digital Lending for Credit Unions and Community Banks through its Partnership with MeridianLink

Eltropy Advances Digital Lending for Credit Unions and Community Banks through its Partnership with MeridianLink

Milestone adoption brings Eltropy's AI-powered communication platform to MeridianLink's digital lending platforms at more than 100 financial institutions
'This 100th integration marks a significant shift in the digital experience ... It's about making digital lending feel as personal as a branch visit.' — Ashish Garg, Co-founder and CEO, Eltropy
SANTA CLARA, CA, UNITED STATES, February 14, 2025 / EINPresswire.com / -- Eltropy, the leading AI-powered conversations platform for community financial institutions (CFIs), today announced its 100th customer integration with MeridianLink, Inc. (NYSE: MLNK), a leading provider of modern software platforms for financial institutions and consumer reporting agencies. This milestone highlights the growing adoption of embedded communications in online account opening and digital lending.
This achievement spans implementations across the MeridianLink® Consumer, MeridianLink® Opening, and MeridianLink® Collect offerings, allowing credit unions and community banks to reduce friction across the entire banking journey by directly embedding Eltropy's unified conversations platform. This integration allows members to connect with agents via text, chat, video, or phone call during critical moments of the application process.
'This 100th integration marks a significant shift in the digital experience,' said Ashish Garg, Co-founder and CEO of Eltropy. 'Credit unions and community banks want to offer modern digital experiences without losing their personal touch. For example, by embedding communication directly into MeridianLink's lending workflow, we're helping them achieve both – members get instant support when they need it most, and CFIs see higher completion rates. It's about making digital lending feel as personal as a branch visit.'
The integration routes interactions from loan pages specifically to lending departments, enabling applicants to receive expert assistance and accelerated loan processing. Financial institutions can also deploy Eltropy's AI-powered platform to handle routine queries about application status, loan rates, and payments.
The platform's capabilities extend beyond lending to support the full banking lifecycle – from digital account opening and loan origination through collections, with additional integrations in development. This comprehensive approach allows for consistent communication across all member touchpoints.
'We're seeing tremendous momentum in adoption of these integrations,' said Jason Smith, VP of Strategic Partnerships at Eltropy. 'Beyond our current milestone, we have numerous community financial institutions in the implementation pipeline who recognize the value of embedded communications. We're also exploring several promising opportunities to expand our collaboration with MeridianLink® to bring even more innovative solutions to CFIs.'
Community financial institutions using the integrated solution report significant improvements in both operational efficiency and member satisfaction:
'Using Eltropy's text platform within our MeridianLink system has made a substantial difference. We can quickly and easily reach out to borrowers, give them updates in real-time, and share important documents through text messages,' said Debbie Possin, AVP Member Contact Center, America's Credit Union. 'This speeds up loan approvals and keeps borrowers happy by using a communication method they prefer. Having Eltropy integrated into MeridianLink makes everything smoother – our team gets more done, and our members get better service throughout their entire loan process.'
'The integration of Eltropy and MeridianLink has dramatically improved our lending operations,' said Courtney Spaid, Director of Lending at Tri-County Area Federal Credit Union. 'Our lenders can now work on multiple loans simultaneously while maintaining constant communication with members. The ability to text directly from within our loan origination system means faster document collection and quicker loan closings. It's made our team more efficient while improving the member experience through their preferred communication channel.'
To learn more about Eltropy's MeridianLink integration capabilities, visit eltropy.com or request a demo.
About Eltropy
Eltropy is the leading conversations platform for community financial institutions (CFIs). Its AI-driven communications tools empower CFIs to communicate, automate, improve operations and engagement, and increase productivity across the institution – all while maintaining the highest standards of security and compliance. Using Eltropy's platform, CFIs can connect with and service their members and customers anytime, anywhere via Text, Chat, Video, Voice — all integrated into a single platform. For more information, please visit eltropy.com.
About MeridianLink
MeridianLink® (NYSE: MLNK) empowers financial institutions and consumer reporting agencies to drive efficient growth. MeridianLink's cloud-based digital lending, account opening, background screening, and data verification solutions leverage shared intelligence from a unified data platform, MeridianLink® One, to enable customers of all sizes to identify growth opportunities, effectively scale up, and support compliance efforts, all while powering an enhanced experience for staff and consumers alike.
For more than 25 years, MeridianLink has prioritized the democratization of lending for consumers, businesses, and communities. Learn more at www.meridianlink.com.
Steve Jensen
X
LinkedIn
Instagram
YouTube
Legal Disclaimer:

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GRUPO SIMEC SAB DE CV ANNOUNCES THE PRESENTATION OF DOCUMENT 20F TO THE SEC
GRUPO SIMEC SAB DE CV ANNOUNCES THE PRESENTATION OF DOCUMENT 20F TO THE SEC

Yahoo

time28 minutes ago

  • Yahoo

GRUPO SIMEC SAB DE CV ANNOUNCES THE PRESENTATION OF DOCUMENT 20F TO THE SEC

GUADALAJARA, Mexico, June 11, 2025 /PRNewswire/ -- Grupo Simec, S.A.B. de C.V. (NYSE-MKT: SIM) (the "Company") May 15, 2025 filed its Annual Report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission at The Form 20-F is also available on the investor relations section of the Company's website at Shareholders may request a hard copy of the Form 20-F, including the Company's complete audited financial statements for the year ended December 31, 2024, free of charge, by contacting the Company's Finance coordinator, Mario Moreno Cortez, by email at mmoreno@ About Grupo Simec Grupo Simec is a diversified manufacturer, processor and distributor of SBQ steel and structural steel products with production and commercial operations in Mexico and Brazil, and limited commercial operations in the United States. Grupo Simec is also an important producer of structural and light structural steel products in Mexico in terms of sales volume. Grupo Simec's SBQ products are used across a broad range of highly engineered end-user applications, including axles, hubs and crankshafts for automobiles and light trucks, machine tools and off-highway. Contact: Mario Moreno CortezGrupo Simec, S.A.B. de Lázaro Cárdenas 60144440 Guadalajara, Jalisco, México+52 33 3770 6734 View original content: SOURCE Grupo Simec, S.A.B. de C.V.

Establishment Labs Hosting Investor Day on June 12
Establishment Labs Hosting Investor Day on June 12

Yahoo

time42 minutes ago

  • Yahoo

Establishment Labs Hosting Investor Day on June 12

NEW YORK, June 11, 2025--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, will host its previously announced analyst and investor event in New York City on June 12, 2025 beginning at 1pm ET. A live and archived webcast of presentations and Q&A sessions on June 12 will be available on the "Investors" section of the Establishment Labs website at In-person attendance at the event is limited and requires advanced registration. Please email: ir@ for further information. About Establishment Labs Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women's health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a portfolio of solutions for breast health, breast aesthetics, and breast reconstruction in over 90 countries. With over four million Motiva ® devices delivered to plastic and reconstructive surgeons since 2010, the Company's products have created a new standard for safety and patient satisfaction. The company's minimally invasive platform consists of Mia Femtech®, a unique minimally invasive experience for breast harmonization, and Preservé™, a breast tissue preserving and minimally invasive technology for breast augmentation, revision augmentation and mastopexy augmentation. GEM® is a next generation minimally invasive system for gluteal ergonomic modeling currently undergoing an IRB approved pivotal study. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Zensor™ is an RFID technology platform used to safely identify implantable devices from outside the body, and includes the company's first biosensor Zen°™, currently part of an IRB approved pivotal study to measure core breast temperature. These solutions are supported by over 200 patent applications in 20 separate patent families worldwide and over 100 scientific and clinical studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in Costa Rica compliant with all applicable regulatory standards under ISO13485:2024 and FDA 21 CFR 820. Please visit our website for additional information at View source version on Contacts Investor/Media Contact: Raj Denhoy415 828-1044rdenhoy@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Establishment Labs Hosting Investor Day on June 12
Establishment Labs Hosting Investor Day on June 12

Business Wire

timean hour ago

  • Business Wire

Establishment Labs Hosting Investor Day on June 12

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, will host its previously announced analyst and investor event in New York City on June 12, 2025 beginning at 1pm ET. A live and archived webcast of presentations and Q&A sessions on June 12 will be available on the "Investors" section of the Establishment Labs website at In-person attendance at the event is limited and requires advanced registration. Please email: ir@ for further information. About Establishment Labs Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women's health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a portfolio of solutions for breast health, breast aesthetics, and breast reconstruction in over 90 countries. With over four million Motiva ® devices delivered to plastic and reconstructive surgeons since 2010, the Company's products have created a new standard for safety and patient satisfaction. The company's minimally invasive platform consists of Mia Femtech®, a unique minimally invasive experience for breast harmonization, and Preservé™, a breast tissue preserving and minimally invasive technology for breast augmentation, revision augmentation and mastopexy augmentation. GEM® is a next generation minimally invasive system for gluteal ergonomic modeling currently undergoing an IRB approved pivotal study. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Zensor™ is an RFID technology platform used to safely identify implantable devices from outside the body, and includes the company's first biosensor Zen°™, currently part of an IRB approved pivotal study to measure core breast temperature. These solutions are supported by over 200 patent applications in 20 separate patent families worldwide and over 100 scientific and clinical studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in Costa Rica compliant with all applicable regulatory standards under ISO13485:2024 and FDA 21 CFR 820. Please visit our website for additional information at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store